Marker Therapeutics Inc. (MRKR)
1.16
0.08 (7.41%)
At close: Apr 17, 2025, 3:55 PM
1.10
-5.17%
After-hours: Apr 17, 2025, 07:53 PM EDT
Marker Therapeutics Revenue
Marker Therapeutics reported an annual revenue of $6,591.1B, reflecting a 199058047.17% growth. For the quarter ending December 31, 2024, Marker Therapeutics generated $6,591.1B in revenue.
Revenue (ttm)
$6,591.1B
Revenue Growth
199058047.17%
Price / Sales Ratio
0
Revenue / Employee
$1,318.2B
Employees
5
Market Cap
12.42M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | % Change |
|---|---|---|
| Dec 31, 2024 | 6,591.1B | +199058047.17% |
| Dec 31, 2023 | 3.31M | -63.23% |
| Dec 31, 2022 | 9M | +625.17% |
| Dec 31, 2021 | 1.24M | +166.01% |
| Dec 31, 2020 | 466.79K | n/a |